Ameritas Investment Partners’s Pliant Therapeutics PLRX Stock Holding History

Ameritas Investment Partners’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,614	Closed	-$7.58K	–	3306
2025 Q1	$7.58K	Hold	5,614	–	–	﹤0.01%	2894
2024 Q4	$73.9K	Hold	5,614	–	–	﹤0.01%	1960
2024 Q3	$62.9K	Hold	5,614	–	–	﹤0.01%	2060
2024 Q2	$60.4K	Hold	5,614	–	–	﹤0.01%	2036
2024 Q1	$83.6K	Hold	5,614	–	–	﹤0.01%	1853
2023 Q4	$102K	Hold	5,614	–	–	﹤0.01%	1721
2023 Q3	$97.3K	Buy	5,614 +948	+20%	+$16.4K	﹤0.01%	1676
2023 Q2	$84.5K	Buy	+4,666	New	+$110K	﹤0.01%	1710
2022 Q2	–	Sell	-1,954	Closed	-$14K	–	3195
2022 Q1	$14K	Hold	1,954	–	–	﹤0.01%	2690
2021 Q4	$26K	Hold	1,954	–	–	﹤0.01%	2519
2021 Q3	$33K	Hold	1,954	–	–	﹤0.01%	2417
2021 Q2	$57K	Hold	1,954	–	–	﹤0.01%	2099
2021 Q1	$77K	Buy	1,954 +1,066	+120%	+$34.6K	﹤0.01%	1810
2020 Q4	$20K	Hold	888	–	–	﹤0.01%	2479
2020 Q3	$20K	Buy	+888	New	+$22.2K	﹤0.01%	2378

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Ameritas Investment Partners's PLRX Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 5,614 shares — an estimated $7.58K sold.

Ameritas Investment Partners first reported a position in PLRX in Q3 2020 and held it in 15 quarters. The position peaked at $102K in Q4 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

Ameritas Investment Partners reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 5,614 Pliant Therapeutics shares in Q2 2025, an estimated $7.58K.
Ameritas Investment Partners first reported a position in Pliant Therapeutics in Q3 2020 and held it in 15 quarters.
Ameritas Investment Partners's Pliant Therapeutics position peaked at $102K in Q4 2023.
114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.